Does INGENOL MEBUTATE Cause Application site dryness? 365 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 365 reports of Application site dryness have been filed in association with INGENOL MEBUTATE. This represents 12.1% of all adverse event reports for INGENOL MEBUTATE.
365
Reports of Application site dryness with INGENOL MEBUTATE
12.1%
of all INGENOL MEBUTATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Application site dryness From INGENOL MEBUTATE?
Of the 365 reports.
Is Application site dryness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INGENOL MEBUTATE. However, 365 reports have been filed with the FAERS database.
What Other Side Effects Does INGENOL MEBUTATE Cause?
Application site erythema (1,373)
Application site pain (1,012)
Application site vesicles (843)
Application site exfoliation (586)
Drug administered at inappropriate site (500)
Application site swelling (489)
Application site scab (451)
Incorrect drug administration duration (339)
Application site pruritus (291)
Inappropriate schedule of drug administration (250)
What Other Drugs Cause Application site dryness?
MINOXIDIL (1,027)
SUMATRIPTAN (208)
BUPRENORPHINE (100)
TESTOSTERONE (63)
ADAPALENE (60)
DICLOFENAC (55)
ESTRADIOL (52)
ESTRADIOL\NORETHINDRONE (49)
NICOTINE (48)
TRETINOIN (44)
Which INGENOL MEBUTATE Alternatives Have Lower Application site dryness Risk?
INGENOL MEBUTATE vs INLYTA
INGENOL MEBUTATE vs INOTERSEN
INGENOL MEBUTATE vs INOTUZUMAB OZOGAMICIN
INGENOL MEBUTATE vs INSULIN
INGENOL MEBUTATE vs INSULIN ASPART